Acquiring Company
ARMADA ACQUISITION CORP. III
Acquired Company
Brains Bioceutical
Description
Armada Acquisition Corp. III has agreed to merge with Brains Bioceutical Corp. in a transaction valuing Brains at approximately $750 million before the merger. The combined company, Brains Therapeutics Corp., is expected to trade on Nasdaq under the ticker BAPI. The companies expect to complete the deal in the second quarter of 2027, subject to shareholder, regulatory and exchange approvals.
Quick answer
ARMADA ACQUISITION CORP. III is acquiring Brains Bioceutical, announced November 17, 2026. ARMADA ACQUISITION CORP. III is based in Philadelphia, Pennsylvania, United States.
- How much did ARMADA ACQUISITION CORP. III pay for Brains Bioceutical?
- The deal value was not disclosed.
- What does ARMADA ACQUISITION CORP. III do?
- Armada Acquisition Corp. III is a special purpose acquisition company (SPAC) based in the Cayman Islands, focused on pursuing mergers, asset acquisitions, stock purchases, and similar business combinations with..
- Where are ARMADA ACQUISITION CORP. III and Brains Bioceutical based?
- ARMADA ACQUISITION CORP. III is based in Philadelphia, Pennsylvania, United States. Brains Bioceutical is based in Vancouver, British Columbia, Canada.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical and Artificial Intelligence
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Zeria Pharmaceutical acquires Haupt Pharma Wulfling (October 25, 2026)
- Laprophan acquires Corporate Investment Holding (October 21, 2026)
- Sai Parenterals to acquire Bion's Rx unit (November 17, 2026)
- Gedeon Richter to acquire Mayne Pharma at $6.40/share (November 16, 2026)
- PAI Pharma acquires Nexus Pharmaceuticals (November 12, 2026)
- Lonza to acquire Merck's CDMO unit for €-mid-triple (November 3, 2026)
Who to call at ARMADA ACQUISITION CORP. III, and when
When ARMADA ACQUISITION CORP. III changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day ARMADA ACQUISITION CORP. III raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ARMADA ACQUISITION CORP. III, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ARMADA ACQUISITION CORP. III. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ARMADA ACQUISITION CORP. III makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Brains Bioceutical?
Brains Bioceutical was acquired by ARMADA ACQUISITION CORP. III, based in Philadelphia. The deal was reported on November 17, 2026. Armada Acquisition Corp. ARMADA ACQUISITION CORP. III is privately held and operates in Artificial Intelligence.
When did ARMADA ACQUISITION CORP. III acquire Brains Bioceutical?
ARMADA ACQUISITION CORP. III's acquisition of Brains Bioceutical was reported on November 17, 2026. Armada Acquisition Corp. III has agreed to merge with Brains Bioceutical Corp. in a transaction valuing Brains at approximately $750 million before the merger. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Brains Bioceutical do?
Brains Bioceutical Corp. is a global leader in natural GMP-compliant cannabinoid pharmaceuticals. It is privately held, operating in Manufacturing, and is based in Vancouver.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.